biote Corp.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
BTMD$1.08-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2025 | 30,713,367 | $3 | 5,221,653 | $1 | $— | $(49,549) | $(29) | $(8,965) | $(58,539) | $8,142 | $(50,397) |
| Distributions | — | — | — | — | — | — | — | — | — | (405) | (405) |
| Net income | — | — | — | — | — | 2,277 | — | — | 2,277 | 399 | 2,676 |
| Other comprehensive income | — | — | — | — | — | — | 2 | — | 2 | — | 2 |
| Share-based compensation | — | — | — | — | — | 1,758 | — | — | 1,758 | — | 1,758 |
| Class A common stock repurchased | (726,388) | — | — | — | — | — | — | (1,071) | (1,071) | — | (1,071) |
| TRA liability | — | — | — | — | — | (518) | — | — | (518) | — | (518) |
| Balance at March 31, 2026 | 29,986,979 | $3 | 5,221,653 | $1 | $— | $(46,032) | $(27) | $(10,036) | $(56,091) | $8,136 | $(47,955) |
| Distributions | — | — | — | — | — | — | — | — | — | (616) | (616) |
| Net loss | — | — | — | — | — | (6,563) | — | — | (6,563) | (865) | (7,428) |
| Other comprehensive income (loss) | — | — | — | — | — | — | 2 | — | 2 | — | 2 |
| Share-based compensation | — | — | — | — | — | 1,970 | — | — | 1,970 | — | 1,970 |
| Vesting of RSUs | 82,419 | — | — | — | — | (922) | — | — | (922) | 922 | — |
| Issuance of stock under purchase plans | 28,366 | — | — | — | — | 26 | — | — | 26 | 21 | 47 |
| Class A common stock repurchased | (2,436,177) | — | — | — | — | — | — | (4,792) | (4,792) | — | (4,792) |
| TRA liability | — | — | — | — | — | 580 | — | — | 580 | — | 580 |
| Balance at June 30, 2026 | 27,661,587 | $3 | 5,221,653 | $1 | $— | $(50,941) | $(25) | $(14,828) | $(65,790) | $7,598 | $(58,192) |
| Distributions | — | — | — | — | — | — | — | — | — | (8) | (8) |
| Net income | — | — | — | — | — | 407 | — | — | 407 | 162 | 569 |
| Other comprehensive income (loss) | — | — | — | — | — | — | (3) | — | (3) | (1) | (4) |
| Share-based compensation | — | — | — | — | — | 1,342 | — | — | 1,342 | — | 1,342 |
| Class A common stock repurchased | (621,498) | — | — | — | — | — | — | (1,362) | (1,362) | — | (1,362) |
| TRA liability | — | — | — | — | — | 57 | — | — | 57 | — | 57 |
| Balance at September 30, 2026 | 27,040,089 | $3 | 5,221,653 | $1 | $— | $(49,135) | $(28) | $(16,190) | $(65,349) | $7,751 | $(57,598) |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2024 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(100,297) | $(35) | $(5,600) | $(105,928) | $3,728 | $(102,200) |
| Distributions | — | — | — | — | — | — | — | — | — | (694) | (694) |
| Net income | — | — | — | — | — | 13,718 | — | — | 13,718 | 2,121 | 15,839 |
| Other comprehensive income (loss) | — | — | — | — | — | — | (4) | — | (4) | — | (4) |
| Share-based compensation | — | — | — | — | — | 2,127 | — | — | 2,127 | — | 2,127 |
| TRA liability | — | — | — | — | — | 106 | — | — | 106 | — | 106 |
| Balance at March 31, 2025 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(84,346) | $(39) | $(5,600) | $(89,981) | $5,155 | $(84,826) |
| Distributions | — | — | — | — | — | — | — | — | — | (887) | (887) |
| Net income | — | — | — | — | — | 3,185 | — | — | 3,185 | 740 | 3,925 |
| Other comprehensive income (loss) | — | — | — | — | — | — | 9 | — | 9 | — | 9 |
| Share-based compensation | — | — | — | — | — | 2,186 | — | — | 2,186 | — | 2,186 |
| Vesting of RSUs | 24,039 | — | — | — | — | (566) | — | — | (566) | 566 | — |
| Issuance of stock under purchase plans | 21,595 | — | — | — | — | 58 | — | — | 58 | 14 | 72 |
| Exercise of stock options | 64,040 | — | — | — | — | (436) | — | — | (436) | 662 | 226 |
| Shares issued in connection with acquisition | 97,276 | — | — | — | — | (14) | — | — | (14) | 14 | — |
| TRA liability | — | — | — | — | — | 455 | — | — | 455 | — | 455 |
| Balance at June 30, 2025 | 31,692,727 | $3 | 5,221,653 | $1 | $— | $(79,478) | $(30) | $(5,600) | $(85,104) | $6,264 | $(78,840) |
| Distributions | — | — | — | — | — | — | — | — | — | (8) | (8) |
| Net income | — | — | — | — | — | 8,188 | — | — | 8,188 | 1,028 | 9,216 |
| Other comprehensive income (loss) | — | — | — | — | — | — | — | — | — | — | — |
| Share-based compensation | — | — | — | — | — | 2,410 | — | — | 2,410 | — | 2,410 |
| Class A common stock repurchased | (1,011,767) | — | — | — | — | — | — | (3,365) | (3,365) | — | (3,365) |
| Legal Settlement - Liabilities | — | — | — | — | — | 6,060 | — | — | 6,060 | — | 6,060 |
| TRA liability | — | — | — | — | — | (940) | — | — | (940) | — | (940) |
| Balance at September 30, 2025 | 30,680,960 | $3 | 5,221,653 | $1 | $— | $(63,760) | $(30) | $(8,965) | $(72,751) | $7,284 | $(65,467) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.